GRAIL, Inc. (GRAL)
NASDAQ: GRAL · Real-Time Price · USD
15.09
+0.30 (2.03%)
At close: Nov 20, 2024, 4:00 PM
15.45
+0.36 (2.39%)
Pre-market: Nov 21, 2024, 7:40 AM EST
GRAIL Market Cap
GRAIL has a market cap or net worth of $507.04 million as of November 21, 2024.
Market Cap
507.04M
Enterprise Value
-274.32M
1-Year Change
n/a
Ranking
Category
Stock Price
Market Cap Chart
Since June 12, 2024, GRAIL's market cap has increased from $362.57M to $507.04M, an increase of 39.84%. That is a compound annual growth rate of 114.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 496.96M | 37.06% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Terns Pharmaceuticals | 484.15M |
| ProKidney | 482.70M |
| Y-mAbs Therapeutics | 480.14M |
| MeiraGTx Holdings | 475.95M |
| Cartesian Therapeutics | 471.95M |
| Perspective Therapeutics | 470.41M |
| Alumis | 470.08M |
| Taysha Gene Therapies | 467.27M |